Lepu Medical Technology (Beijing) Co., Ltd.
300003.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.21B
Close$
$14.36
16.9% upside
Current Fair Value
16.9% upsideUndervalued by 16.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $22.21 Billion |
|---|---|
| Enterprise Value | $24.70 Billion |
| Dividend Yield | $0.33 (2.65%) |
| Earnings per Share | $0.52 |
| Beta | 0.05 |
| Outstanding Shares | 1,843,424,716 |
Return
| Return on Equity | 4.01% |
|---|---|
| Return on Assets | 2.50% |
| Return on Invested Capital | 4.14% |
Valuation & Multiples
| P/E Ratio | 34.51 |
|---|---|
| PEG | -89.46 |
| Price to Sales | 4.1 |
| Price to Book Ratio | 1.37 |
| Enterprise Value to Revenue | 4 |
| Enterprise Value to EBIT | 27 |
| Enterprise Value to Net Income | 37 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 24, 2026
EPS Estimate
$0.13
Average shareholder expectationRevenue Estimate
$1.68 B
Average shareholder expectationNext Earnings Call
Expected Date
April 28, 2027
EPS Estimate
$0.03
Average shareholder expectationRevenue Estimate
$1.61 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lepu Medical Technology (Beijing) Co., Ltd.
8,689 employees
CEO: Fei Pu Established in 1999 and headquartered in Beijing, China, Lepu Medical Technology is a prominent company dedicated to the research, development, production, and sale of a broad spectrum of medical devices, pharmaceuticals, and healthcare ...